Cowan Chad
Chief Scientific Officer
Cowan Chad has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Cowan Chad is listed as Chief Scientific Officer at Century Therapeutics, Inc. Inside the rolling window, Cowan Chad reported 1 open-market purchase totaling $49K in IPSC and 1 open-market sale totaling $3K in IPSC. The largest disclosed transaction in the window is a purchase of 58,060 IPSC shares on Dec 22, 2025, worth $49K.
Companies traded
Other insiders at IPSC
Insider Buying
$49K
reported purchases (SEC code P)
Insider Selling
$3K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cowan Chad made?
Cowan Chad has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Cowan Chad trade?
Cowan Chad has filed SEC Form 4 disclosures for 1 company, including IPSC.
When was Cowan Chad's most recent SEC Form 4 filing?
Cowan Chad's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Cowan Chad's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cowan Chad is listed as Chief Scientific Officer.
What is Cowan Chad's total buy and sell value in the current window?
Inside the rolling retention window, Cowan Chad bought $49K and sold $3K based on SEC Form 4 filings.
What was Cowan Chad's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 58,060 IPSC shares on 2025-12-22, worth $49K, per SEC Form 4 filings.